How have AMST and SONM total returns compared?

Over the past 5 years, AMST delivered -45.94% and SONM delivered -60.09% annualized total return. Past performance doesn't predict future results.

Amesite Inc. (AMST) vs DNA X, Inc. (SONM)

A side-by-side comparison of Amesite Inc. and DNA X, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AMST

Amesite Inc.

$6M

$0.93TechnologyDelayed quote: Oct 6, 2026, 4:00 PM EDT

SONM

DNA X, Inc.

$6M

$3.99TechnologyDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AMST vs SONM

growth of $100 · dividends reinvested · last 6y

AMST -98.5% (-50.3%/yr)SONM -99.7% (-62.1%/yr)AMST compounded faster over this window

Log scale — wide-divergence pair

AMST SONM

AMST vs SONM: by the numbers

•AMST is the larger company ($6M vs $6M market cap).
•Both run net losses; SONM's is the smaller (0.00% vs -848.69% net margin).

Metrics side by side

Valuation

Metric	AMST	SONM
P/E ratio	N/A	1.92
P/S ratio	16.70	N/A
P/B ratio	2.30	N/A

Profitability

Metric	AMST	SONM
Gross margin	23.95%	0.00%
Operating margin	-861.65%	0.00%
Net margin	-848.69%	0.00%
ROE	-116.66%	N/A
ROIC	-118.44%	-238.40%

Growth (annualized)

Metric	AMST	SONM
Revenue CAGR (5Y)	-11.57%	N/A
Total return CAGR (5Y)	-45.94%	-60.09%

Frequently asked

How have AMST and SONM total returns compared?: Over the past 5 years, AMST delivered -45.94% and SONM delivered -60.09% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AMST analysis Full SONM analysis Interactive comparison tool

Dig into the metrics

DNA X P/E ratio Amesite ROE DNA X ROE Amesite operating margin DNA X operating margin Amesite revenue growth DNA X revenue growth Amesite free cash flow DNA X free cash flow

Amesite & DNA X appear in these rankings

Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.